Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Free Cash Flow Generation Index
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A free cash flow generation index. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a Free Cash Flow Generation Index of 0.36x as of September 2025. Free cash flow of CN¥9.52 Million represents 0% of operating cash flow (CN¥26.54 Million). Check 002864 financial resilience to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)
Free cash flow generation index of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. Historical FCF Generation Index trend for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A across 13 annual periods. Explore 002864 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Free Cash Flow Generation Index by Year (2013–2025)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A free cash flow generation index by year from 2013 to 2025. Year-by-year Free Cash Flow Generation Index for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A. For the full cash flow conversion analysis, see Shaanxi Panlong Pharmaceutical Group Lim cash conversion from operations.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.33x | CN¥20.60 Million | CN¥63.01 Million | CN¥42.41 Million | ▼ -31.3% |
| 2024 | 0.48x | CN¥74.54 Million | CN¥156.59 Million | CN¥82.05 Million | ▲ +19.2% |
| 2023 | 0.40x | CN¥41.53 Million | CN¥104.05 Million | CN¥62.51 Million | ▼ -28.0% |
| 2022 | 0.55x | CN¥69.53 Million | CN¥125.36 Million | CN¥55.84 Million | ▲ +82.0% |
| 2021 | 0.30x | CN¥35.36 Million | CN¥116.04 Million | CN¥80.68 Million | ▲ +33.5% |
| 2020 | 0.23x | CN¥21.06 Million | CN¥92.24 Million | CN¥71.18 Million | ▼ -54.9% |
| 2019 | 0.51x | CN¥34.34 Million | CN¥67.89 Million | CN¥33.55 Million | ▼ -11.5% |
| 2018 | 0.57x | CN¥26.78 Million | CN¥46.85 Million | CN¥20.06 Million | ▲ +225.2% |
| 2017 | 0.18x | CN¥5.00 Million | CN¥28.45 Million | CN¥23.45 Million | ▼ -75.7% |
| 2016 | 0.72x | CN¥44.94 Million | CN¥61.99 Million | CN¥17.06 Million | ▲ +760.6% |
| 2015 | -0.11x | CN¥-4.46 Million | CN¥40.62 Million | CN¥45.08 Million | ▼ -133.0% |
| 2014 | 0.33x | CN¥16.13 Million | CN¥48.56 Million | CN¥32.42 Million | ▲ +265.1% |
| 2013 | -0.20x | CN¥-5.12 Million | CN¥25.43 Million | CN¥30.55 Million | — |